FeesSafety
Pluang+

nDatalyze appoints new CEO D’Arcy Funfer, focuses on commercializing EpitomePD sports platform.

Company Fundamentals
18 Nov 2026, 14:15 WIB
TheNewswire
View Source
Bullish
nDatalyze appoints new CEO D’Arcy Funfer, focuses on commercializing EpitomePD sports platform.

nDatalyze Corp. has appointed D’Arcy Funfer as its new President and CEO, with Jim Durward stepping down to become Chairman of the Board. Funfer also replaces Gordon Crawford as a Director. The company is now focusing on commercializing its advanced athletic assessment platform, EpitomePD, which targets hockey and other high-performance sports markets. They also granted 3.7 million stock options to directors and officers at $0.05 per share, valid for two years.

nDatalyze Corp.'s recent leadership changes and stock option grants provide context for readers. For those tracking the Technology sector, 109 of 150 US stocks rose while 34 fell on Pluang. Notable movers include QBTS at USD 8.43 with a 4.33% gain, CORZ at USD 14.08 up 4.22%, and CIFR at USD 6.69 rising 4.21%, as of Nov 18, 2026 18:01 WIB.

More News

Microsoft shares drop 2.27% after global outages despite Oppenheimer's Outperform rating

Microsoft shares drop 2.27% after global outages despite Oppenheimer's Outperform rating

Microsoft's stock fell 2.27% to $506.24 following global outages affecting its Copilot, Teams, and Outlook services. The outages, attributed to server issues rather than cyberattacks, raised concerns amid broader software sector weakness. Oppenheimer...

Market News
Bearish
49 minutes ago
Target posts strongest sales growth in 5 years, raises annual sales growth target to 6%.

Target posts strongest sales growth in 5 years, raises annual sales growth target to 6%.

Target Corporation reported earnings per share of $2.65, beating estimates of $2.08, and revenue of $27.1 billion, surpassing the $26.5 billion forecast. The company achieved its strongest quarterly sales growth in about five years, with net sales up...

Company Fundamentals
Bullish
55 minutes ago
Aquestive Therapeutics to present at Piper Sandler Healthcare Conference on Dec 2, 2026

Aquestive Therapeutics to present at Piper Sandler Healthcare Conference on Dec 2, 2026

Aquestive Therapeutics announced its participation in the Piper Sandler 38th Annual Healthcare Conference from December 1-3, 2026, in New York City. CEO Daniel Barber will present on December 2 at 10:30 am ET, with one-on-one investor meetings schedu...

Market News
Neutral
1 hour ago
Raymond James upgrades Charles Schwab to Strong Buy as client assets hit $13.27T in Oct 2026

Raymond James upgrades Charles Schwab to Strong Buy as client assets hit $13.27T in Oct 2026

Raymond James upgraded Charles Schwab to Strong Buy following strong growth in October 2026. Client assets rose 12% year over year to $13.27 trillion, with core net new assets surging 50% to $66.5 billion, a record for the month. Schwab also opened 4...

Analyst Insights
Bullish
2 hours ago
SDVerse named CES Innovation Awards 2027 Honoree for AI-powered automotive software marketplace.

SDVerse named CES Innovation Awards 2027 Honoree for AI-powered automotive software marketplace.

SDVerse, a B2B automotive software marketplace founded by General Motors, Magna, and Wipro, was honored with a CES Innovation Award 2027 in the Enterprise Tech category. The platform uses AI and standardized technical data to help automakers and supp...

Others
Bullish
2 hours ago
banner-footerbanner-footer

Invest & Trade with
#1 Award-Winning Investment Super App